Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1978-04-25
1979-04-10
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
2601125R, A61K 3700, C07C10352
Patent
active
041488865
ABSTRACT:
The novel thymic factor polypeptide hormone, elaborated by the thymus and und in the blood serum, is isolated. The hormone is useful for the treatment of autoimmune diseases and for selectively stimulating T-cell activity in aging subjects.
REFERENCES:
patent: 4002740 (1977-01-01), Goldstein et al.
patent: 4010148 (1977-03-01), Goldstein
patent: 4082737 (1978-04-01), McGregor et al.
Bach Jean-Francois
Hamburger Jean
Institute National de la Sante & de la Recherche Medicale (INSER
Patton Walter
Phillips Delbert R.
Westlake, Jr. Harry E.
LandOfFree
Polypeptide possessing thymic activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polypeptide possessing thymic activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polypeptide possessing thymic activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1071331